Due to the implication of MAPT in both AD neuropathology1, 7, 20 and risk,14, 15, 18 we performed MAPT haplotype–stratified association analyses in the genotype data from the ADGC to test the hypothesis that AD risk variants may exhibit MAPT haplotype‐dependent association. The gene discussed is MAPT; the disease is Alzheimer disease.